Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10,094 | $7,768 | $0 | $0 |
| % Growth | 29.9% | – | – | – |
| Cost of Goods Sold | $7,765 | $4,741 | $0 | $0 |
| Gross Profit | $2,329 | $3,027 | $0 | $0 |
| % Margin | 23.1% | 39% | – | – |
| R&D Expenses | $40,448 | $86,655 | $81,876 | $68,838 |
| G&A Expenses | $3,400 | $34,752 | $30,215 | $23,474 |
| SG&A Expenses | $40,101 | $34,752 | $30,215 | $23,474 |
| Sales & Mktg Exp. | $36,701 | $0 | $0 | $0 |
| Other Operating Expenses | $58,481 | $0 | $0 | $0 |
| Operating Expenses | $139,030 | $121,407 | $112,091 | $92,312 |
| Operating Income | -$136,701 | -$118,380 | -$112,091 | -$92,312 |
| % Margin | -1,354.3% | -1,523.9% | – | – |
| Other Income/Exp. Net | $6,665 | $1,722 | $1,873 | $25 |
| Pre-Tax Income | -$130,036 | -$116,658 | -$110,218 | -$92,287 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$130,036 | -$116,658 | -$110,218 | -$92,287 |
| % Margin | -1,288.3% | -1,501.8% | – | – |
| EPS | -176.6 | -6,368.84 | -811.68 | -163,968 |
| % Growth | 97.2% | -684.6% | 99.5% | – |
| EPS Diluted | -176.6 | -6,368.84 | -811.68 | -163,968 |
| Weighted Avg Shares Out | 2,264 | 1,832 | 3,069 | 1 |
| Weighted Avg Shares Out Dil | 2,264 | 1,832 | 3,069 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1,873 | $25 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,421 | $4,291 | $1,253 | $50 |
| EBITDA | -$74,323 | -$114,089 | -$110,838 | -$92,262 |
| % Margin | -736.3% | -1,468.7% | – | – |